THC vs Alcohol: What the Evidence Really Says About Your Heart, Brain, and Cancer Risk

Two of the most common recreational drugs, two very different risk profiles. Here is what the peer-reviewed science actually shows about cannabis and alcohol — the harms, the myths, and the few genuine benefits — across the three systems that matter most for a long, healthy life.

“Is weed better for me than alcohol?” is now one of the most common questions in primary care — and it deserves a real, evidence-based answer rather than a cultural one. Both THC (the psychoactive compound in cannabis) and alcohol are widely used, widely rationalized, and widely misunderstood. The honest summary is that neither is a health product, but their risks fall in strikingly different places: alcohol’s dangers are best established for cancer and the aging brain, while cannabis’s most concerning signals are for the heart and the developing or psychosis-prone brain. This review compares them head-to-head across cardiometabolic health, brain health, and cancer risk, weighs any real benefits, and links every major claim to its academic source so you can read the primary evidence yourself.

---

The Big Picture: Two Drugs, Two Different Risk Maps

The single most useful idea in this comparison is that THC and alcohol are not dangerous in the same ways, so a blanket ranking misleads. Alcohol is a proven human carcinogen with dose-dependent harm to the brain and heart that shows up over years and decades. Cannabis carries a lower established cancer burden but a rising set of cardiovascular concerns and well-documented risks to the adolescent brain and mental health. One is a slow, systemic toxin; the other is a potent neuroactive and cardioactive drug whose long-term data are still maturing as legal, high-potency products flood the market. Below, we take each system in turn — and finish with a side-by-side table and answers to the questions patients ask most.

---

Cardiometabolic Health: The Heart and Blood Vessels

Alcohol: the J-curve was largely a mirage

For decades, the story was that moderate drinking protected the heart — the famous “J-shaped curve.” That belief has not survived better methods. Using Mendelian randomization in the UK Biobank, researchers found that once you account for the fact that light drinkers tend to be healthier and wealthier to begin with, the apparent protection largely disappears, and cardiovascular risk rises steeply as intake climbs. A 2024 “burden of proof” analysis likewise found the evidence for any heart benefit from alcohol is weak. Alcohol also reliably raises blood pressure, and even one drink can measurably increase the odds of an atrial fibrillation episode in susceptible people — the phenomenon long known as “holiday heart,” now confirmed with continuous monitoring. Heavy use additionally weakens the heart muscle itself (alcoholic cardiomyopathy).

Cannabis: a real and growing cardiovascular concern

THC acutely raises heart rate and can transiently spike blood pressure, and the population data are now catching up to that pharmacology. A large study in the Journal of the American Heart Association linked cannabis use to higher odds of heart attack and stroke, with risk rising by frequency of use — and notably, these signals appeared even among people who did not smoke tobacco. A 2025 multicenter analysis in JACC: Advances reported a substantially increased risk of myocardial infarction in cannabis users, including younger adults. Because much of this evidence is observational and confounded by how cannabis is used (often smoked, often alongside tobacco), causation isn’t settled — but the American Heart Association now flags cannabis as a genuine cardiovascular risk worth discussing, especially for anyone with existing heart disease.

---

Brain Health: Cognition, Mood, and the Long Game

Alcohol: even “moderate” drinking tracks with a smaller brain

This is where the newest data are most sobering. In a study of more than 36,000 adults, researchers found that alcohol intake was associated with reductions in both gray and white matter in the brain — and the association began at light-to-moderate levels, not just heavy drinking. Going from one to two drinks a day was linked to brain changes comparable to aging the brain by roughly two years. Chronic heavy drinking is an established, independent risk factor for dementia and causes distinct alcohol-related brain damage. The takeaway isn’t panic over an occasional glass of wine; it’s that alcohol’s effect on brain structure is real, dose-dependent, and starts lower than most people assume.

Cannabis: the risk is concentrated in youth and in psychosis

Cannabis’s brain risks are less about slow shrinkage and more about timing and potency. The adolescent and young-adult brain is still developing into the mid-twenties, and regular use during this window is associated with lasting effects on attention, memory, and learning. The best-established serious risk is psychosis: the landmark EU-GEI study in The Lancet Psychiatry found that daily use of high-potency cannabis was associated with roughly a five-fold higher risk of a first psychotic disorder compared with never-users. As legal products have grown far more potent, this is not a fringe concern. Cannabis also carries a meaningful risk of cannabis use disorder (dependence), and heavy use is linked to anxiety and, in some, cannabinoid hyperemesis syndrome.

---

Cancer Risk: Where the Two Drugs Diverge Most

Alcohol: a Group 1 carcinogen behind seven cancers

This is the clearest and most under-appreciated fact in the whole comparison. Alcohol is classified as a Group 1 carcinogen — the same category as tobacco and asbestos — and in January 2025 the U.S. Surgeon General issued a formal Advisory on Alcohol and Cancer Risk, calling for cancer warning labels. Alcohol is causally linked to at least seven cancers: breast, colorectal, liver, esophageal, and cancers of the mouth, throat, and voice box. The risk begins at low levels of drinking — there is no clearly “safe” amount for cancer — and it drives an estimated ~100,000 cancer cases and 20,000 cancer deaths a year in the U.S. alone. The main mechanism is acetaldehyde, a DNA-damaging chemical the body makes as it breaks down alcohol.

Cannabis: not a clear carcinogen — but not exonerated

Cannabis does not have anything close to alcohol’s cancer case. A 2024 overview in The Lancet Public Health concluded the evidence linking cannabis to most cancers is limited and inconsistent, and it is not classified as a Group 1 carcinogen. That said, the picture is not clean: smoking cannabis delivers many of the same combustion products and tar as tobacco smoke, and a systematic review found an association between cannabis use and testicular germ cell tumors. The honest status, echoed by the CDC, is that we lack the long-term, high-quality data to declare cannabis cancer-safe — especially smoked, high-potency, long-term use. On cancer specifically, though, alcohol is in a different and clearly worse league.

---

Are There Any Real Health Benefits?

Alcohol: essentially no proven health benefit

The evidence-based answer is deflating for the “glass of red wine” narrative: there is no level of alcohol that improves health, and the once-cited cardiovascular benefit has largely been explained away by confounding, as the 2024 burden-of-proof analysis and Mendelian randomization work above show. Any polyphenols in wine are available from grapes, berries, and other foods without the carcinogen attached. Alcohol’s role, if any, is social and psychological — not physiological.

Cannabis: real therapeutic uses, for specific conditions

Cannabis is different here, and it’s important to be fair to the evidence. The National Academies of Sciences, Engineering, and Medicine concluded there is conclusive or substantial evidence that cannabis or cannabinoids help with three things: chronic pain in adults, chemotherapy-induced nausea and vomiting, and spasticity from multiple sclerosis. Separately, a purified plant-derived cannabidiol (CBD) medication, Epidiolex, is FDA-approved for rare severe epilepsies (Dravet and Lennox-Gastaut syndromes). These are real, meaningful benefits — but they are specific medical indications under clinical supervision, and they do not translate into recreational THC being a wellness tool. Alcohol has no comparable therapeutic profile.

---

THC vs Alcohol: At a Glance

“Val” highlights the domain where each substance carries its most distinctive, best-established risk. This table summarizes population-level evidence and is not a substitute for individual medical advice.

---

The Long View

The wrong question is “which is safer” — the right one is “safer for what, and for whom”

The instinct to crown a winner between THC and alcohol is understandable, but the evidence resists it. If your dominant concern is cancer and long-term brain aging, alcohol carries the heavier, better-proven burden — a Group 1 carcinogen with dose-dependent damage to the brain that the latest imaging shows starting lower than we used to believe. If your concern is cardiovascular events or mental health in a young or psychosis-prone person, cannabis’s risks move to the front, sharpened by today’s high-potency products and a still-thin long-term evidence base.

What both share is more important than what separates them: neither is a health-promoting substance, and the harms of both are dose-dependent, meaning less is genuinely better and none is safest. The most defensible position is not tribal — it is individualized. A postmenopausal woman with a family history of breast cancer and a young man with a family history of schizophrenia are asking the same question and should get very different answers, because the same two drugs press on their specific vulnerabilities in opposite ways.

That is exactly the logic of precision prevention: not population slogans, but a read of your biology, history, and risk. The value of the evidence above isn’t to license one substance and condemn the other — it’s to let you and your physician make a decision that fits the actual person, with clear eyes about what each choice costs.

---

Frequently Asked Questions

---

Putting It Into Practice